The FIRST oral chew to deliver flea and tick protection for up to 12 full weeks. Safe for breeding, pregnant, and lactating dogs. Suitable for dogs and puppies over 2kg in weight and 8 weeks or older.
Open the Bravecto Pamphlet here by clicking here.
What is Bravecto?
Bravecto is the first oral chew to provide up to 12 weeks of protection against fleas and ticks. For the treatment and prevention of tick and flea infestations in dogs. BRAVECTO® kills adult, as well as juvenile ticks (larvae and nymphs). BRAVECTO® can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
With one chew, Bravecto is easier to give and less to worry about for you! Suitable for dogs and puppies (over 2kg and 8 weeks of age or older).
Tip: Bravecto can be given to your dog any time of the day, however it is recommended that you give your dog Bravecto at a mealtime, with food.
Please consult with your veterinarian if you are unsure of anything or if you are wanting to try Bravecto for the first time.
More Info
Features:
- One chew is effective for 12 weeks - 3 times longer than regular monthly doses
- Starts working within 2 hours to kill fleas and treat and control ticks
- No more monthly dosing, messy topicals or fussy collars!
- Tasty oral chew your dog will take as a treat
- Unlike topical applications, there's no need to separate pets after giving your dog Bravecto
How it works: After giving your dog Bravecto, the medication quickly reaches tissue fluids under your dog's skin. When fleas and ticks feed on your dog, they ingest Bravecto and die.
More Information:
Active Ingredient(s): Fluralaner
How is Bravecto administered: Bravecto should be administered orally as a single dose every 12 weeks according to the dosage schedule to provide a minimum dose of 11.4 mg/lb (25 mg/kg) body weight. Treatment with Bravecto may begin at any time of the year and can continue year round without interruption.
How should I store this product: Do not store above 30°C - keep in a dry place.
Reg. No. G4083 (Act 36/1947)
Pharmacodynamic properties: Fluralaner is an acaricide and insecticide. It is efficacious against ticks (Ixodes spp., Dermacentor spp. , and Rhipicephalus sanguineus) and fleas (Ctenocephalides spp.) on the dog. Fluralaner is systemically active on target parasites. Contact activity against ticks and fleas is of minor relevance. Fluralaner is a potent inhibitor of parts of the arthropod nervous system by acting antagonistically on ligand-gated chloride channels (GABA-receptor and glutamate-receptor). In a molecular on target study, Fluralaner is not affected by dieldrin resistance. In vitro, Fluralaner overcomes resistance against amidines, organophosphates, cyclodienes, macrocyclic lactones, phenylpyrazoles, benzophenyl ureas, pyrethroids and carbamates. In vivo, Fluralaner is highly effective against fleas proven to be less susceptible to phenylpyrazole insecticides.
Pharmacokinetic particulars: Following oral administration, Fluralaner is readily absorbed reaching maximum plasma concentrations within one day. Food enhances the absorption. Fluralaner is systemically distributed and reaches the highest concentrations in the visceral fat, followed by liver, kidney and muscle. The prolonged persistence and slow elimination from plasma (t½ = 12 days) and the lack of extensive metabolism provide effective concentrations of Fluralaner for the duration of the inter-dosing interval, ensuring efficacy for 12 weeks. The major route of elimination is the excretion of unchanged Fluralaner in faeces (~90 % of the dose). Renal clearance is the minor route of elimination.
Warnings:
- Safety in puppies less than 8 weeks old and/or dogs weighing less than 2 kg has not been established.
- Keep the product in the original packaging until use.
- KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND PETS.
- Can be used in breeding, pregnant and lactating dogs.
- Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
Precautions:
- Do not eat, drink or smoke while handling the product.
- Wash hands thoroughly with soap and water immediately after use of the product.
- Do not store with food, drinks, medication or household products.
Directions for Use:
- Administer tablets at or around the time of feeding for maximum effectiveness.
- It can be mixed with food or given by hand since it is very palatable.
- For optimal control of tick and flea infestation, BRAVECTO® should be administered at intervals of 12 weeks.
- BRAVECTO® can be administered all year round.
Overdose: BRAVECTO® was well tolerated following oral administration to puppies aged 8 - 9 weeks and weighing 2,0 - 3,6 kg at doses of up to 56, 168 and 280 mg Fluralaner/kg body weight (equivalent to 1, 3 and 5 times the maximum expected clinical dose) on 3 occasions at 8-week intervals. No treatment-related adverse effects were observed.
There were no findings on reproductive performance and offspring viability when up to 168 mg/kg of Fluralaner (equivalent to 3 times the maximum treatment dose) was administered orally to Beagle dogs.
Efficacy: BRAVECTO® was shown to be effective* against fleas and various tick species.
* Efficacy > 90 - 95 %
BRAVECTO® is indicated for the treatment of the following:
Ticks: (Ixodes ricinus, Ixodes hexagonus, Ixodus scapularis, Dermacentor reticulatus, Dermacentor variabilis and Rhipicephalus sanguineus)
Directly after treatment, at least 90 % of ticks on the dog are killed within 8 hours. During the whole treatment interval, at least 90 % of ticks on dogs are killed within 12 hours.
Fleas: Ctenocephalides felis
Directly after treatment, at least 95 % of fleas are killed within 8 hours. During the whole treatment interval, at least 95 % of fleas on dogs are killed within 12 hours.
Effect on immature stages
The product kills adult as well as juvenile ticks (larvae, nymphs). Newly emerged fleas on a dog are killed before viable eggs are produced. An in vitro study also demonstrated that very low concentrations of Fluralaner stop the production of viable eggs by fleas.
Control of Flea Infestations and Flea Allergy Dermatitis (FAD)
The flea life cycle is broken due to the rapid onset action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. BRAVECTO® effectively controls environmental flea populations in areas to which the dog has access. BRAVECTO® can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Presentation: Light to dark brown chewable tablet with a smooth or slightly rough surface and circular shape. Some marbling, speckles or both may be visible. Packaged in aluminium foil blister with aluminium foil lid stock.
Sizes
Sizes:
Each pack contains a single dose of Bravecto for 3 month's protection.
* Miniature (Toy) Dogs - 2 to 4.5kg
* Small Dogs - 4.6 to 10kg
* Medium Dogs - 10.1 to 20kg
* Large Dogs - 20.1 to 40kg
* X-Large Dogs - 40.1 to 56 kg
For dogs weighing more than 56kg, use a combination of two tablets that most closely matches your dog's body weight.
Reviews
